Alternatives to Joint Surgery in Arlington, TX

What I’d check before adding joint pain alternatives to surgery here

Joe Bradley will tell you the same thing he tells his own staff: epidemiology first, then MAC, then SKU. CDC PLACES (2023, crude) estimates 12% of adults in Arlington have diagnosed diabetes — about even with the U.S. 12% figure. 18.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. Then we pick joint pain alternatives to surgery against that mix.

Epidemiology is not a protocol

• Adult arthritis here is 21.2% (CDC PLACES 2023, crude). That is the joint-pain backdrop for PRP and orthobiologics — not a promise that every arthritic knee is a candidate. 18.4% of adults 18–64 here currently lack health insurance (CDC PLACES ACCESS2, 2023). Cash-pay PRP and Medicare CTPs cannot share one consent script. PRP is autologous and not a 361 allograft, but “patient prefers regenerative” is still not medical necessity in Texas.
• City-proper population of 394,266 is a Census figure, not a clinic count. It tells you the size of the catchment, not how many biologic vendors already call on the orthopedic group down the street.
• Texas includes counties CDC has described as part of the Diabetes Belt, so diabetic-complication volume is a standing planning input for wound-care and regenerative programs — not a seasonal talking point. Clinics asking for regenerative inventory still have to separate HCT/P 361 homologous-use products from unapproved “stem cell” claims (FDA 21 CFR 1271).

Uninsured mix and Medicare CTPs in the same building

JH reviewers still want serial wound measurements and conservative-care history before CTPs, whether diabetes in Arlington is 12% or not. PLACES is planning data. The LCD is the claim.

Before the first joint pain alternatives to surgery shipment